Ai Chi Method for Children With Asthma

Universidade Federal do Rio Grande do Norte42 enrolled

Overview

This study has the aim to assess the effectiveness of the Ai Chi method as an adjunct therapy in the treatment of children with asthma.

Children from 7 to 12 years old with asthma diagnosis will be included. Children assigned to the control group will receive, along with their parents, educational interventions in relation to asthma, based on guidelines of Global Strategy for Asthma Management and Prevention Revised 2017.Children in the intervention group will perform 12 sessions (twice a week) of treatment with the Ai Chi Method and educational interventions similiar to the control group. The investigators will assess pulmonary function (spirometry), asthma control by the Childhood Asthma Control Test (c-ACT Questionnaire), quality of life by the PAQLQ (Paediatric Asthma Quality of Life Questionnaire), anxiety symptoms by the SCAS (Spence Children's Anxiety Scale) and Disturbed Sleep by the Sleep Disorders Scale in Children. In addition, information will be collected on the numbers of hospitalizations, occurence of absence in school due to exacerbation of the disease, asthma symptoms and Beta2-agonists usage.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

Conditions

Asthma Child Respiratory Disease Hydrotherapy Respiratory Tract Diseases Respiratory Hypersensitivity Respiration Disorders

Interventions

Ai ChiOTHER

Children in the intervention group will perform 12 sessions (twice a week 40 minutes each session) of treatment with the Ai Chi Method, and educational intervention in relation to asthma.

Asthma educationOTHER

Children assigned to the control group will receive, along with their parents, educational interventions in relation to asthma.

Eligibility

Sex: ALLMin age: 7 YearsMax age: 12 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Children from 7 up to 12 years old with asthma diagnose; * Regular inhaled corticosteroids with no change in dose in the preceding 4 weeks; * Children cannot present: other respiratory disease (such as cystic fibrosis, bronchiectasis, tuberculosis), obesity, retinal detachment, hypertensive crisis, congenital heart defect, pulmonary edema, history of lobectomy or lung segmentectomy, respiratory infections 15 days prior to the evaluations. Exclusion Criteria: * Children that are not able to perform some of the necessary procedures; * Give up participating in the research and present acute symptoms of respiratory tract during the assessments.

Locations (1)

Universidade Federal do Rio Grande do Norte (UFRN)

Natal, Rio Grande do Norte, Brazil

RECRUITING

Outcomes

Primary Outcomes

Change in Lung function (spirometry).

Forced expiratory volume in one second (FEV1), forced vital capacity (FVC), FEV1/FVC ratio, forced expiratory flow between 25-75% of the pulmonary volume (FEF25-75).